TCL Archive Chemoprevention Concept Approved By DCPC Bard Uses Biological Markers To Assess Risk Modulation September 27, 1985
TCL Archive Ax Falls; Recision Asked Of $17 Million For NCI This Year, $42.7 Million Cut In FY 1981 Budget April 4, 1980
TCL Archive ODAC Says Clear Clinical Benefit Required When Sponsors Claim Progression Delay July 17, 2009